Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248

Molecular Cancer Therapeutics

Volumn 7, Issue 8, 2008, Pages 2536-2546

  Bagley, Rebecca G ^a   Rouleau, Cecile ^a   St Martin, Thia ^a   Boutin, Paula ^a   Weber, William ^a   Ruzek, Melanie ^a   Honma, Nakayuki ^b   Nacht, Mariana ^a   Shankara, Srinivas ^a   Kataoka, Shiro ^b   Ishida, Isao ^b   Roberts, Bruce L ^a   Teicher, Beverly A ^a  

^a GENZYME CORPORATION   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD31 ANTIGEN; CD45 ANTIGEN; ENDOSIALIN; ENDOSIALIN ANTIBODY; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BLOOD VESSEL; BONE MARROW; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TUMOR VASCULARIZATION; UPREGULATION;

ANTIGENS, CD; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53349173701     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0050     Document Type: Article

References (44)

1. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 2004;54:4564-8.
2. McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002;62:5381-5.
3. St. Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science 2002;289:1197-202.
4. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A 1992;89:10832-6.
5. Christian S, Ahorn H, Koehler A, et al. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem 2001;276:7408-14.
6. Tomkowicz B, Rybinski K, Foley B, et al. Interaction of endosialin/TEM 1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci U S A 2007;104:17965-70.
7. Huber MA, Kraut N, Schweifer N, et al. Expression of stromal cell markers in distinct compartments of human skin cancers. J Cutan Pathol 2006;33:145-55.
8. Rmali KA, Puntis MCA, Jiang WG. Prognostic values of tumor endothelial markers in patients with colorectal cancer. World J Gastroenterol 2005;11:1283-6.
9. Brady J, Neal J, Sadakar N, Gasque P. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. J Neuropath Exp Neurology 2004;63:1274-83.
10. Nanda A, Karim B, Peng Z, et al. Tumor endothelial marker 1 (TEM1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A 2006;103:3351-6.
11. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
12. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
13. Duda D, Cohen K, Kozin S, et al. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006;107:2774-6.
14. Goa D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in lung mouse metastasis. Science 2008;319:195-8.
15. Shirakawa K, Shibuya M, Heike Y, et al. Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer 2002;99:344-51.
16. Bian X, Du L, Shi J, Cheng Y, Liu F. Correlation of bFGF, FGFR-1, and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol 2000;22:267-74.
17. Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005;105:3286-94.
18. Dome B, Timar J, Dobos J, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66:7341-7.
19. + lymphatic/vascular endothelial precursor cells. Blood 2003;101:168-72.
20. Shmelkov SV, St. Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005;37:715-9.
21. Bagley RG, Walter-Yohrling J, Cao X, et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison to mature endothelial cells. Cancer Res 2003;63:5866-73.
22. Bagley RG, Weber W, Rouleau C, Teicher BA. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res 2005;65:9741-50.
23. Madden SL, Cook BP, Nacht M, et al. Vascular gene expression in non-neoplastic and malignant brain. Am J Pathol 2004;165:601-8.
24. Tomizuka K, Shinohara T, Yoshida H, et al. Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy n loci and expression of fully human antibodies. Proc Natl Acad Sci U S A 2000;97:722-7.
25. Opavsky R, Haviernik P, Jurkovicova D, et al. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 2001;276:38795-807.
26. Tentori L, Vergati M, Muzi A, et al. Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. Int J Cancer 2005;27:525-35.
27. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 2004; 11:811-8.
28. Udani V, Santarelli J, Yung Y, et al. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors. Neurol Res 2005;27:801-6.
29. Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG. Levels of expression of endothelial markers specific to tumor-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004;21:31-7.
30. Bolontrade MF, Zhou R, Kleinerman ES. Vasculogenesis plays a role in the growth of Ewing's sarcoma in vivo. Clin Cancer Res 2002;8:3622-7.
31. Li H, Gerald W, Benezra R. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Cancer Res 2004;64:6137-43.
32. Peters B, Diaz L, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-2.
33. Shaked Y, Bertolini F, Man S, et al. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005;7:101-11.
34. Capillo M, Mancuso P, Gobbi A, et al. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin Cancer Res 2003;9:377-82.
35. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201.
36. Nolan DJ, Ciarrocchi A, Mellick AS, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007;21:1546-58.
37. Furstenberger G, von Moos R, Lucas R, et al. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006;94:524-31.
38. Zheng PP, Hop WC, Luider TM, Sillevis Smitt PA, Kros JM. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Ann Neurol 2007;62:40-8.
39. Yu D, Sun X, Qiu Y, et al. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007;13:3814-24.
40. Dean YD, McGreal EP, Akatsu H, Gasque P. Molecular and cellular properties of the rat AA4 antigen, a C-type lectin-like receptor with structural homology to thrombomodulin. J Biol Chem 2000;275:34382-92.
41. Marty C, Langer-Machova Z, Sigrist S, Schott, Schwendener RA, Ballmer-Hofer K. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. Cancer Lett 2005;235:1-11.
42. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogeneis therapy? Nature 2002;2:826-35.
43. Shaked Y, Ciarrocchi A, Franco M, et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006;313:1785-7.
44. Shaked Y, Kerbel RS. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Res 2007;67:7055-8.